Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012

Site Feasibility and Study Start Up

17 Oct 2012 - 18 Oct 2012 - London, UK

Bookmark and Share

The majority of clinical trials overrun due to poor site feasibility and less than 50% of sites meet study enrolment goals – discover how to avoid this in your own study start up by attending Informa’s Site Feasibility and Study Start Up conference this October.

With 14+ industry led case studies and 18+ site feasibility and study start up experts on hand to answer your questions, this event is not to be missed.

Our 2012 expert speaker panel includes:

Vibeke Breinholt, Director Clinical Operations, Ferring Pharmaceuticals, Denmark

Holly Edgar, Associate Director, Late Phase Clinical Development & Operations Astellas Pharma Europe, UK

John Needham, (Former Senior Director, Recruitment Strategy, Johnson & Johnson Pharmaceutical Research and Development (JJPRD), USA)

Dr Rajeev Chavda, Medical Director, Pierre-Fabre Group, India

Get your questions answered by leading industry experts in our interactive round table discussions. Visit the event website for the full agenda and speaker line up.

Further information
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Multi-Gene Test Enables Some Breast Cancer Patients to Safely Avoid Chemotherapy
A major study is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack?
Heart attack patients live as long – or even longer – on one-quarter the suggested dose.
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Electronic Reminders Keep TB Patients on Track With Medication In China
Giving electronic reminders to tuberculosis (TB) patients in China can reduce the amount of medication doses they miss by half, according to new research.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos